Business - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Business
News, articles, and updates about business activities in the bio/pharmaceutical industry.

GSK Fined in China Bribery Scandal

September 19, 2014

GSK is found guilty of offering bribes to doctors and is find $489 million.

AbbVie to Acquire Shire for $54.7 Billion

July 18, 2014

After rejecting several bids, Shire has agreed to a merger with AbbVie valued at almost $55 billion.

Mylan to Acquire Abbott's Non-US Businesses in $5.3 Billion Stock Deal

July 14, 2014

Mylan set to acquire Abbott's non-US developed markets specialty and branded generics business in an all-stock transaction.

Pharma Capacity to Produce Cytotoxic Injectable Drugs Constricts

June 29, 2014
PTSM: Pharmaceutical Technology Sourcing and Management

PharmSource special report shows demand for cytotoxic injectable drugs could tap existing CMO capacity.

Changing Market Dynamics Require New Approaches to Innovation

June 29, 2014
PTSM: Pharmaceutical Technology Sourcing and Management

Pharma companies are looking to external sources for innovations that meet future needs.

More than 430 New Medicines in Development for Chronic Diseases

June 26, 2014

PTSM: Pharmaceutical Technology Sourcing and Management

PhRMA announced 430 new medicines in development to treat chronic diseases affecting older Americans.

Bureaucratic Roadblocks Threaten Biopharma Growth

June 2, 2014

Pharmaceutical Technology

Protecting intellectual property rights is vital to biopharmaceutical innovation.

Kymab Receives $40 Million Investment From Gates Foundation and Wellcome Trust

May 22, 2014

Kymab receives $40 million investment for clinical development of antibody therapeutics.

AstraZeneca Rejects Pfizer's Final Offer

May 19, 2014

AstraZeneca rejects Pfizer's final offer of $118 billion for a proposed merger of the two companies.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
Click here